Skip to main content
SteadySharesSteadySharesSteadyStShares
The market
MarketsDiscover
Follow the money
Super InvestorsPolitician TradesCrypto Desk
Yours
My WealthNews
Settings Sign in
Pre-market
SteadySharesMarketsDiscoverSuper InvestorsMy WealthPoliticiansCryptoNews
DiscoverSGRY
HealthcareNMSUSD

Surgery Partners, Inc.

$0012345678900123456789.0012345678900123456789-4.6%
52w low $11.41$23.44 52w high
Market data · updated 22h ago
Market data
Market cap
$2.06B
52w range
$11.41 - $23.44
Beta
1.89
Sector
Healthcare
Data quality
83/100
Valuation
fair value estimate
$13.03
Margin of safety
-1.5%
Forward P/E
23.5x
Quality & efficiency
Moat score
22/100
Return on equity
2.7%
Profit margin
-2.3%
Debt / equity
1.16
Growth & analysts
Revenue growth
+4.5%
Analyst target
$18.64
Target upside
+40.9%
Analysts
11
Run the 10-point checklist before you buy How these numbers are made

About Surgery Partners, Inc.

Surgery Partners, Inc., together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery. It offers emergency departments; ancillary services such as physician practices and diagnostic testing; multi-specialty physician practices; urgent care facilities; and anesthesia services. In addition, it offers single- and multi-specialty facilities. Surgery Partners, Inc. was founded in 2004 and is headquartered in Brentwood, Tennessee.

Valuation

ValueGrowthProfitHealthIncome27QUALITY
Overall Rating
22
Very low quality
Very low quality

Derived from filed metrics · High confidence (83% of the inputs available)

Moat Score22
Fair value estimate
$13.03-1.5% downside

Moat, fair value and rating computed by our valuation engine (ported from the original Python model).

Fundamentals

Market Cap
$2.06B
P/E Ratio
N/A
Dividend Yield
0.00%
Revenue Growth
+4.5%
Profit Margin
-2.3%
ROE
2.7%
Debt / Equity
1.16
Beta
1.89

Statistics

Similar Stocks · Healthcare

Latest News · SGRY